NCS1 and cardiac hypertrophy: We have previously demonstrated that phenylephrine-induced cardiac hypertrophy was significantly attenuated in NCS-1 KO hearts concomitant with a reduced activation of both calcineurin/NFAT and CaMKII/HDAC pathways [11].